Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BBC
Virtus LifeSci Biotech Clinical Trials ETF
$23.08
+1.9%
$21.17
$13.42
$31.65
$16.15M1.0845,338 shs16,028 shs
GDOC
Goldman Sachs Future Health Care Equity ETF
$32.50
+0.8%
$31.47
$28.34
$37.23
$20.48M0.841,330 shs1,474 shs
MEDI
Harbor Health Care ETF
$27.81
+1.3%
$26.85
$21.86
$28.50
$17.52M12,818 shs5,130 shs
MEDX
Horizon Kinetics Medical ETF
$28.94
+0.9%
$27.54
$23.46
$32.00
$16.98M0.911,786 shs313 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BBC
Virtus LifeSci Biotech Clinical Trials ETF
0.00%+0.57%+3.59%+27.58%-17.41%
GDOC
Goldman Sachs Future Health Care Equity ETF
0.00%+1.85%+1.94%+5.66%-11.37%
MEDI
Harbor Health Care ETF
0.00%+0.22%+0.91%+13.88%+1.35%
MEDX
Horizon Kinetics Medical ETF
0.00%+1.54%+2.99%+13.16%-8.78%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BBC
Virtus LifeSci Biotech Clinical Trials ETF
N/AN/AN/AN/AN/AN/AN/AN/A
GDOC
Goldman Sachs Future Health Care Equity ETF
N/AN/AN/AN/AN/AN/AN/AN/A
MEDI
Harbor Health Care ETF
N/AN/AN/AN/AN/AN/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BBC
Virtus LifeSci Biotech Clinical Trials ETF
2.94
Moderate Buy$23.08N/A
GDOC
Goldman Sachs Future Health Care Equity ETF
2.79
Moderate Buy$32.50N/A
MEDI
Harbor Health Care ETF
2.87
Moderate Buy$27.81N/A
MEDX
Horizon Kinetics Medical ETF
2.64
Moderate Buy$28.94N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BBC
Virtus LifeSci Biotech Clinical Trials ETF
N/AN/AN/AN/AN/AN/A
GDOC
Goldman Sachs Future Health Care Equity ETF
N/AN/AN/AN/AN/AN/A
MEDI
Harbor Health Care ETF
N/AN/AN/AN/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BBC
Virtus LifeSci Biotech Clinical Trials ETF
N/AN/A0.00N/AN/AN/AN/AN/A
GDOC
Goldman Sachs Future Health Care Equity ETF
N/AN/A28.36N/AN/AN/AN/AN/A
MEDI
Harbor Health Care ETF
N/AN/A35.66N/AN/AN/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
N/AN/A19.02N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BBC
Virtus LifeSci Biotech Clinical Trials ETF
$0.231.00%N/AN/AN/A
GDOC
Goldman Sachs Future Health Care Equity ETF
N/A0.02%N/AN/AN/A
MEDI
Harbor Health Care ETF
$0.130.47%N/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
$0.501.73%N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
BBC
Virtus LifeSci Biotech Clinical Trials ETF
N/A700,000N/ANot Optionable
GDOC
Goldman Sachs Future Health Care Equity ETF
N/A630,000N/ANot Optionable
MEDI
Harbor Health Care ETF
N/A630,000N/ANot Optionable
MEDX
Horizon Kinetics Medical ETF
N/A590,000N/ANot Optionable

Media Sentiment Over Time

Top Headlines

View All Headlines

Virtus LifeSci Biotech Clinical Trials ETF NYSEARCA:BBC

$23.08 +0.44 (+1.94%)
As of 08/22/2025 04:10 PM Eastern

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.

Goldman Sachs Future Health Care Equity ETF NYSEARCA:GDOC

$32.50 +0.25 (+0.78%)
As of 08/22/2025 04:10 PM Eastern

The Goldman Sachs Future Health Care Equity ETF (GDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to equities of companies that are driving innovation in healthcare globally. GDOC was launched on Nov 9, 2021 and is managed by Goldman Sachs.

Harbor Health Care ETF NYSEARCA:MEDI

$27.81 +0.35 (+1.27%)
As of 08/22/2025 04:10 PM Eastern

The Harbor Health Care ETF (MEDI) is an exchange-traded fund that is based on the Russell 3000 Growth Health Care index. The fund seeks long-term capital growth by actively managing a narrow portfolio of stocks engaged in the health care sector globally. MEDI was launched on Nov 16, 2022 and is managed by Harbor.

Horizon Kinetics Medical ETF NASDAQ:MEDX

$28.94 +0.26 (+0.92%)
Closing price 08/22/2025 11:32 AM Eastern
Extended Trading
$28.80 -0.14 (-0.48%)
As of 08/22/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is managed by Horizon Kinetics.